AU4738879A - Anti-inflammatory compositions - Google Patents

Anti-inflammatory compositions

Info

Publication number
AU4738879A
AU4738879A AU47388/79A AU4738879A AU4738879A AU 4738879 A AU4738879 A AU 4738879A AU 47388/79 A AU47388/79 A AU 47388/79A AU 4738879 A AU4738879 A AU 4738879A AU 4738879 A AU4738879 A AU 4738879A
Authority
AU
Australia
Prior art keywords
inflammatory compositions
inflammatory
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU47388/79A
Other versions
AU528798B2 (en
Inventor
Adolph Edward Sloboda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of AU4738879A publication Critical patent/AU4738879A/en
Application granted granted Critical
Publication of AU528798B2 publication Critical patent/AU528798B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU47388/79A 1978-08-01 1979-05-24 Anti-inflammatory compositions Ceased AU528798B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93030078A 1978-08-01 1978-08-01
US930300 1978-08-01

Publications (2)

Publication Number Publication Date
AU4738879A true AU4738879A (en) 1980-02-07
AU528798B2 AU528798B2 (en) 1983-05-12

Family

ID=25459165

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47388/79A Ceased AU528798B2 (en) 1978-08-01 1979-05-24 Anti-inflammatory compositions

Country Status (6)

Country Link
AU (1) AU528798B2 (en)
BE (1) BE877950A (en)
CH (1) CH641959A5 (en)
DE (1) DE2930039A1 (en)
PH (1) PH18639A (en)
ZA (1) ZA792562B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0419890A3 (en) * 1989-09-29 1991-05-29 American Cyanamid Company Stable pharmaceutical formulations for antineoplastic compounds having more than one ethyleneimine group, and method
US6335339B1 (en) 1998-01-13 2002-01-01 Scriptgen Pharmaceuticals, Inc. Triazine antiviral compounds
CA2318362A1 (en) * 1998-01-13 1999-07-22 Sharon T. Cload Triazine antiviral compounds

Also Published As

Publication number Publication date
PH18639A (en) 1985-08-23
ZA792562B (en) 1980-08-27
DE2930039A1 (en) 1980-02-21
AU528798B2 (en) 1983-05-12
BE877950A (en) 1980-01-28
CH641959A5 (en) 1984-03-30

Similar Documents

Publication Publication Date Title
AU528892B2 (en) Polymer-polyol compositions
AU531536B2 (en) Dental compositions
AU524350B2 (en) Thermogenic compositions
AU531143B2 (en) Photopolymerisable compositions
AU4894779A (en) Retard compositions
AU4344579A (en) Nitro-bromo-alkanol compositions
AU527280B2 (en) Cementitious compositions
AU532040B2 (en) Curable compositions
AU523448B2 (en) Oral compositions
AU523719B2 (en) Coating compositions
AU524592B2 (en) Photopolymerizable composition
AU529093B2 (en) Anaerobic compositions
AU527052B2 (en) Adhesive compositions
AU526347B2 (en) Polyarylene ester compositions
AU523773B2 (en) Benzodiazepine compositions
AU522517B2 (en) Explosive compositions
AU4520979A (en) Pigment compositions
AU530738B2 (en) Fasciolicidal compositions
AU528798B2 (en) Anti-inflammatory compositions
AU4867579A (en) Pharmaceutical compositions with increased hypotensive effects
AU523405B2 (en) Pharmaceutical compositions
AU526125B2 (en) Antiviral compositions
AU526625B2 (en) Coating compositions
AU4733879A (en) Coating compositions
AU525362B2 (en) Bactericidal compositions